Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

ACON

Aclarion (ACON)

Aclarion Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ACON
일자시간출처헤드라인심볼기업
2024/04/2522:14GlobeNewswire Inc.Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back PainNASDAQ:ACONAclarion Inc
2024/03/0706:09Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ACONAclarion Inc
2024/03/0422:00GlobeNewswire Inc.Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar DiscsNASDAQ:ACONAclarion Inc
2024/02/2805:22GlobeNewswire Inc.Aclarion Announces Closing of $3.0 Million Public OfferingNASDAQ:ACONAclarion Inc
2024/02/2804:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
2024/02/2800:46Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ACONAclarion Inc
2024/02/2714:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACONAclarion Inc
2024/02/2623:15GlobeNewswire Inc.Aclarion Announces Pricing of $3.0 Million Public OfferingNASDAQ:ACONAclarion Inc
2024/02/2401:46Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ACONAclarion Inc
2024/02/2207:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
2024/02/2205:02Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ACONAclarion Inc
2024/02/0707:32Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ACONAclarion Inc
2024/02/0522:00GlobeNewswire Inc.Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic PartnershipNASDAQ:ACONAclarion Inc
2024/02/0214:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACONAclarion Inc
2024/02/0207:16Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ACONAclarion Inc
2024/02/0107:26Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ACONAclarion Inc
2024/01/2920:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
2024/01/2323:53Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
2024/01/2306:48Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ACONAclarion Inc
2024/01/2222:00GlobeNewswire Inc.Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MDNASDAQ:ACONAclarion Inc
2024/01/1722:00GlobeNewswire Inc.Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan SolutionNASDAQ:ACONAclarion Inc
2024/01/1306:15Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ACONAclarion Inc
2024/01/0822:00GlobeNewswire Inc.Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of NociscanNASDAQ:ACONAclarion Inc
2024/01/0422:01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ACONAclarion Inc
2024/01/0422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
2024/01/0302:00GlobeNewswire Inc.Aclarion Announces Reverse Stock SplitNASDAQ:ACONAclarion Inc
2023/12/2920:30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ACONAclarion Inc
2023/12/2006:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
2023/12/1206:55Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ACONAclarion Inc
2023/11/2722:00GlobeNewswire Inc.Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan ExamsNASDAQ:ACONAclarion Inc
 검색 관련기사 보기:NASDAQ:ACON